Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%

Trials by Status

completed267%
withdrawn133%

Recent Activity

0 active trials
Showing 3 of 3
completed

SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access

NCT02214134
completed

Screening Platform for Clinical Trials in Advanced Colorectal Cancer

NCT01723969
withdrawn

SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access

NCT02307604

Clinical Trials (3)

Showing 3 of 3 trials
NCT02214134

SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access

Completed
NCT01723969

Screening Platform for Clinical Trials in Advanced Colorectal Cancer

Completed
NCT02307604

SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
3